Easy-to-deliver mRNA treatment shows promise for stopping flu and COVID-19 viruses
Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
4 March 2021Rio tightens restrictions as COVID surges in Brazil
4 March 2021Easy-to-deliver mRNA treatment shows promise for stopping flu and COVID-19 viruses
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes COVID-19. Best of all, the treatment could be delivered to the lungs via a nebulizer, making it easy for patients to administer themselves at home.
